Back to All Events

2025 BIO CEO & Investor Conference


  • Marriott Marquis 1535 Broadway New York, NY, 10036 United States (map)

Event Details

Event Overview

Cizzle Bio is pleased to announce that we will be attending the 2025 BIO CEO & Investor Conference, one of the largest and most influential investor conferences in the biotech industry. This event, taking place on February 10-11, 2025, at the Marriott Marquis in New York City, serves as a premier gathering for biotech executives, institutional investors, industry analysts, and key stakeholders focused on the future of life sciences and healthcare investment.

About the BIO CEO & Investor Conference

The BIO CEO & Investor Conference is designed to foster business development and investment in the biotech sector. The conference features:

  • Keynote presentations from leading biotech executives and investors

  • Panel discussions on emerging biotech trends and market outlooks

  • Networking opportunities with top industry leaders

  • One-on-one meetings to explore potential partnerships and collaborations

This event is an excellent opportunity to gain insight into the latest biotech innovations, investment strategies, and market dynamics shaping the future of healthcare.

Why Cizzle Bio is Attending

At Cizzle Bio, we are dedicated to advancing early cancer detection through biomarker-based diagnostics. Our CIZ1B Lung Cancer Test and DEX-G2 Gastric Cancer Test are designed to identify cancer in its earliest stages, improving patient outcomes and survival rates.

Attending the BIO CEO & Investor Conference allows us to:

  • Engage with industry leaders to explore advancements in cancer diagnostics

  • Connect with investors interested in innovative healthcare solutions

  • Network with potential partners to expand our impact on early cancer detection

  • Stay at the forefront of biotech investment and emerging trends

Join Us in New York

If you’re attending the BIO CEO & Investor Conference, we’d love to connect and discuss how Cizzle Bio is working to revolutionize early cancer detection.

For more information about the event, visit: BIO CEO & Investor Conference

Stay tuned for updates as we continue our mission to Detect Early. Save Lives.

 
Previous
Previous
January 23

2025 ASCO Gastrointestinal Cancers Symposium

Next
Next
February 27

2025 Texas BioLife Summit